Article citationsMore>>

Tokunaga, M., Mizusawa, J., Machida, N., Fukagawa, T., Katai, H., Nishida, Y., et al. (2017) Phase III Trial to Evaluate the Efcacy of Neoadjuvant Chemotherapy with S-1 plus Oxaliplatin Followed by D2 Gastrectomy with Adjuvant S-1 in Locally Advanced Gastric Cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial). Journal of Clinical Oncology, 35, TPS4134.
https://doi.org/10.1200/JCO.2017.35.15_suppl.TPS4134

has been cited by the following article:

• TITLE: Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

  AUTHORS: Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

  KEYWORDS: Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 30, 2023

  ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.